Novel Approach With Double Agent Artificial Oocyte Activation for Repeated Fertilization Failure Due to Combined Sperm and Oocyte Factor (CISC)
Calcium Ionophore Together With Strontium Chloride Would Likely Have a Positive But Non-traumatic Impact on Human Embryo Development
Sponsor: Al Baraka Fertility Hospital
Listed as NCT02418416, this NA trial focuses on Infertility and remains completed. Sponsored by Al Baraka Fertility Hospital, it has been updated 7 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Oct 2018 — Jan 2021 [monthly]
Completed NA
▶ Show 2 earlier versions
-
Jun 2018 — Oct 2018 [monthly]
Completed NA
-
Jan 2017 — Jun 2018 [monthly]
Completed NA
First recorded
May 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Al Baraka Fertility Hospital
- Banon IVF Center Assiut, Egypt
- Ibn Sina Hospital
For direct contact, visit the study record on ClinicalTrials.gov .